Skip to content

Prospective study of laparoscopic lateral lymph node dissection for rectal cancer

Prospective study of laparoscopic lateral lymph node dissection for rectal cancer - Prospective study of laparoscopic lateral lymph node dissection for rectal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033355
Enrollment
90
Registered
2018-07-10
Start date
2018-03-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

None listed

Sponsors

Multi-Center Clinical Study Group of Osaka; Colorectal Cancer Treatment Group (MCSGO)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Rectal cancer is proved histologically by biopsy of rectal primary tumor. 2. Preoperative findings indicate clinical stage II or III.

Exclusion criteria

Exclusion criteria: 1. Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ or mucosal carcinoma 2. Cases with uncontrollable diabetes 3. Cases with uncontrollable congestive heart failure, angina pectoris, hypertension, arrhythmia 4. It is judged that psychosis or psychiatric symptoms are merged and it is difficult to participate in the study. 5. In addition, it is a case that the doctor in charge judged that registration of this study is inappropriate.

Design outcomes

Primary

MeasureTime frame
Safety; rate of Grade 3 or 4 adverse events

Secondary

MeasureTime frame
Blood loss, Operation time, sexual function, urinary function, relapse free survival rate, and overall survival rate

Countries

Japan

Contacts

Public ContactJunichi Nishimura

Osaka International Cancer Institute Department of Gastroenterological surgery

jnishimura@gesurg.med.osaka-u.ac.jp0669451181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026